LifeTech Scientific Corporation (HKG:1302)

Hong Kong · Delayed Price · Currency is HKD

1.515

-0.060 (-3.81%)

Nov 11, 2026, 4:08 PM HKT

Market Cap	7.02B -20.7%
Revenue (ttm)	1.49B -2.5%
Net Income	67.43M -18.8%
EPS	0.01 -26.6%
Shares Out	4.63B
PE Ratio	107.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,230,000
Open	1.575
Previous Close	1.575
Day's Range	1.505 - 1.575
52-Week Range	1.255 - 2.380
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing,... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1999

Employees 1,254

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1302

Full Company Profile

Financial Performance

In 2025, LifeTech Scientific's revenue was 1.37 billion, an increase of 5.07% compared to the previous year's 1.30 billion. Earnings were 147.83 million, a decrease of -33.53%.

Financial numbers in CNY Financial Statements